These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37043224)

  • 1. Ketamine vs Electroconvulsive Therapy for Major Depressive Episode: A Systematic Review and Meta-analysis.
    Menon V; Varadharajan N; Faheem A; Andrade C
    JAMA Psychiatry; 2023 Jun; 80(6):639-642. PubMed ID: 37043224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode: A Systematic Review and Meta-analysis.
    Rhee TG; Shim SR; Forester BP; Nierenberg AA; McIntyre RS; Papakostas GI; Krystal JH; Sanacora G; Wilkinson ST
    JAMA Psychiatry; 2022 Dec; 79(12):1162-1172. PubMed ID: 36260324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of ketamine-assisted electroconvulsive therapy in major depressive episode: a systematic review and network meta-analysis.
    Rhee TG; Shim SR; Popp JH; Trikalinos TA; Rosenheck RA; Kellner CH; Seiner SJ; Espinoza RT; Forester BP; McIntyre RS
    Mol Psychiatry; 2024 Mar; 29(3):750-759. PubMed ID: 38123725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder.
    Dean RL; Hurducas C; Hawton K; Spyridi S; Cowen PJ; Hollingsworth S; Marquardt T; Barnes A; Smith R; McShane R; Turner EH; Cipriani A
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD011612. PubMed ID: 34510411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Ketamine-assisted Electroconvulsive Therapy in Major Depressive Episode: A Systematic Review and Network Meta-Analysis.
    Rhee TG; Shim SR; Popp J; Trikalinos T; Rosenheck R; Kellner C; Seiner S; Espinoza R; Forester B; McIntyre R
    Res Sq; 2023 Aug; ():. PubMed ID: 37609159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketamine and other glutamate receptor modulators for depression in adults.
    Caddy C; Amit BH; McCloud TL; Rendell JM; Furukawa TA; McShane R; Hawton K; Cipriani A
    Cochrane Database Syst Rev; 2015 Sep; (9):CD011612. PubMed ID: 26395901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine administration in depressive disorders: a systematic review and meta-analysis.
    Fond G; Loundou A; Rabu C; Macgregor A; Lançon C; Brittner M; Micoulaud-Franchi JA; Richieri R; Courtet P; Abbar M; Roger M; Leboyer M; Boyer L
    Psychopharmacology (Berl); 2014 Sep; 231(18):3663-76. PubMed ID: 25038867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and adverse effects of ketamine versus electroconvulsive therapy for major depressive disorder: A systematic review and meta-analysis.
    de A Simoes Moreira D; Gauer LE; Teixeira G; Fonseca da Silva AC; Cavalcanti S; Quevedo J
    J Affect Disord; 2023 Jun; 330():227-238. PubMed ID: 36907464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine versus electroconvulsive therapy for major depressive episode: An updated systematic review and non-inferiority meta-analysis.
    Petrucci ABC; Fernandes JVA; Reis IA; da Silva GHS; Recla BMF; de Mendonça JC; Pedro VCS; D'Assunção LEN; Valiengo LDCL
    Psychiatry Res; 2024 Sep; 339():115994. PubMed ID: 38865906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy and tolerability of different anesthetics in electroconvulsive therapy for major depressive disorder: A systematic review and network meta-analysis.
    Ren L; Yu J; Zeng J; Wei K; Li P; Luo J; Shen Y; Lv F; Min S
    J Psychiatr Res; 2024 Mar; 171():116-125. PubMed ID: 38271762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review and meta-analysis of randomized controlled trials of adjunctive ketamine in electroconvulsive therapy: efficacy and tolerability.
    McGirr A; Berlim MT; Bond DJ; Neufeld NH; Chan PY; Yatham LN; Lam RW
    J Psychiatr Res; 2015 Mar; 62():23-30. PubMed ID: 25684151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive ketamine in electroconvulsive therapy: updated systematic review and meta-analysis.
    McGirr A; Berlim MT; Bond DJ; Chan PY; Yatham LN; Lam RW
    Br J Psychiatry; 2017 Jun; 210(6):403-407. PubMed ID: 28385704
    [No Abstract]   [Full Text] [Related]  

  • 14. Racemic Ketamine as an Alternative to Electroconvulsive Therapy for Unipolar Depression: A Randomized, Open-Label, Non-Inferiority Trial (KetECT).
    Ekstrand J; Fattah C; Persson M; Cheng T; Nordanskog P; Åkeson J; Tingström A; Lindström MB; Nordenskjöld A; Movahed Rad P
    Int J Neuropsychopharmacol; 2022 May; 25(5):339-349. PubMed ID: 35020871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights for the Use of Ketamine From Randomized Controlled Trials That Compared Ketamine With Electroconvulsive Therapy in Severe Depression.
    Andrade C
    J Clin Psychiatry; 2022 Mar; 83(2):. PubMed ID: 35377565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ELEctroconvulsive therapy (ECT) vs. Ketamine in patients with Treatment-resistant Depression: The ELEKT-D study protocol.
    Mathew SJ; Wilkinson ST; Altinay M; Asghar-Ali A; Chang LC; Collins KA; Dale RM; Hu B; Krishnan K; Kellner CH; Malone DA; Murrough JW; Ostroff RB; Sanacora G; Shao M; Anand A
    Contemp Clin Trials; 2019 Feb; 77():19-26. PubMed ID: 30572160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Ketamine Anesthesia on Efficacy, Tolerability, Seizure Response, and Neurocognitive Outcomes in Electroconvulsive Therapy: A Comprehensive Meta-analysis of Double-Blind Randomized Controlled Trials.
    Ainsworth NJ; Sepehry AA; Vila-Rodriguez F
    J ECT; 2020 Jun; 36(2):94-105. PubMed ID: 31725054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol.
    Phillips JL; Jaworska N; Kamler E; Bhat V; Blier J; Foster JA; Hassel S; Ho K; McMurray L; Milev R; Moazamigoudarzi Z; Placenza FM; Richard-Devantoy S; Rotzinger S; Turecki G; Vazquez GH; Kennedy SH; Blier P;
    BMC Psychiatry; 2020 Jun; 20(1):268. PubMed ID: 32487236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electroconvulsive therapy for treatment-resistant schizophrenia.
    Sinclair DJ; Zhao S; Qi F; Nyakyoma K; Kwong JS; Adams CE
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD011847. PubMed ID: 30888709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive ketamine and electroconvulsive therapy for major depressive disorder: A meta-analysis of randomized controlled trials.
    Zheng W; Li XH; Zhu XM; Cai DB; Yang XH; Ungvari GS; Ng CH; Ning YP; Hu YD; He SH; Wang G; Xiang YT
    J Affect Disord; 2019 May; 250():123-131. PubMed ID: 30852364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.